BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 1561384)

  • 1. Once daily aminoglycoside dosing: maintained efficacy with reduced nephrotoxicity?
    Zhanel GG; Ariano RE
    Ren Fail; 1992; 14(1):1-9. PubMed ID: 1561384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extended-interval aminoglycoside administration for children: a meta-analysis.
    Contopoulos-Ioannidis DG; Giotis ND; Baliatsa DV; Ioannidis JP
    Pediatrics; 2004 Jul; 114(1):e111-8. PubMed ID: 15231982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dosing aminoglycosides once a day].
    Blaser J
    Schweiz Med Wochenschr Suppl; 1996; 76():39S-48S. PubMed ID: 8677418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Once-daily dosing regimen for aminoglycoside plus beta-lactam combination therapy of serious bacterial infections: comparative trial with netilmicin plus ceftriaxone.
    ter Braak EW; de Vries PJ; Bouter KP; van der Vegt SG; Dorrestein GC; Nortier JW; van Dijk A; Verkooyen RP; Verbrugh HA
    Am J Med; 1990 Jul; 89(1):58-66. PubMed ID: 2195890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Daily single-dose aminoglycoside administration. Therapeutic and economic benefits].
    Knudsen LM; Frimodt-Møller N; Hansen MT; Hippe E
    Ugeskr Laeger; 1993 May; 155(19):1436-41. PubMed ID: 8316969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Once-daily dosing of aminoglycosides.
    Blaser J; König C
    Eur J Clin Microbiol Infect Dis; 1995 Dec; 14(12):1029-38. PubMed ID: 8681976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Choice of drug and dosage regimen. Two important risk factors for aminoglycoside nephrotoxicity.
    De Broe ME; Giuliano RA; Verpooten GA
    Am J Med; 1986 Jun; 80(6B):115-8. PubMed ID: 3728523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Once-daily aminoglycoside dosing in immunocompetent adults: a meta-analysis.
    Hatala R; Dinh T; Cook DJ
    Ann Intern Med; 1996 Apr; 124(8):717-25. PubMed ID: 8633831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and ototoxicity.
    Rybak MJ; Abate BJ; Kang SL; Ruffing MJ; Lerner SA; Drusano GL
    Antimicrob Agents Chemother; 1999 Jul; 43(7):1549-55. PubMed ID: 10390201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Once-daily dosing of aminoglycosides: review and recommendations for clinical practice.
    Freeman CD; Nicolau DP; Belliveau PP; Nightingale CH
    J Antimicrob Chemother; 1997 Jun; 39(6):677-86. PubMed ID: 9222035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of once-daily versus pharmacokinetic dosing of aminoglycosides in elderly patients.
    Koo J; Tight R; Rajkumar V; Hawa Z
    Am J Med; 1996 Aug; 101(2):177-83. PubMed ID: 8757358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of netilmicin once or twice daily in preterm newborns: evaluation of nephrotoxicity by urinary alpha1-microglobulin and retinol binding protein.
    Coscia A; Maiorca D; Martano C; Rossi C; Appino I; Cirina P; Alessi D; Fabris C
    J Chemother; 2008 Jun; 20(3):324-6. PubMed ID: 18606587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring serum concentrations for once-daily netilmicin dosing regimens.
    Blaser J; König C; Simmen HP; Thurnheer U
    J Antimicrob Chemother; 1994 Feb; 33(2):341-8. PubMed ID: 8182017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Once-daily dosing decreases renal accumulation of gentamicin and netilmicin.
    Verpooten GA; Giuliano RA; Verbist L; Eestermans G; De Broe ME
    Clin Pharmacol Ther; 1989 Jan; 45(1):22-7. PubMed ID: 2910634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The evolution of aminoglycoside therapy: a single daily dose.
    Deamer RL; Dial LK
    Am Fam Physician; 1996 Apr; 53(5):1782-6. PubMed ID: 8623702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Once-daily aminoglycoside dosing: An update on current literature.
    Stankowicz MS; Ibrahim J; Brown DL
    Am J Health Syst Pharm; 2015 Aug; 72(16):1357-64. PubMed ID: 26246292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What is the evidence for once-daily aminoglycoside therapy?
    Barclay ML; Begg EJ; Hickling KG
    Clin Pharmacokinet; 1994 Jul; 27(1):32-48. PubMed ID: 7955770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of aminoglycosides once-a-day: experimental and clinical data.
    Tulkens PM
    Scand J Infect Dis Suppl; 1990; 74():249-57. PubMed ID: 2097713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Once-daily vs. continuous aminoglycoside dosing: efficacy and toxicity in animal and clinical studies of gentamicin, netilmicin, and tobramycin.
    Powell SH; Thompson WL; Luthe MA; Stern RC; Grossniklaus DA; Bloxham DD; Groden DL; Jacobs MR; DiScenna AO; Cash HA; Klinger JD
    J Infect Dis; 1983 May; 147(5):918-32. PubMed ID: 6860416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation and nephrotoxicity of a simplified once-daily aminoglycoside dosing schedule and guidelines for monitoring therapy.
    Prins JM; Weverling GJ; de Blok K; van Ketel RJ; Speelman P
    Antimicrob Agents Chemother; 1996 Nov; 40(11):2494-9. PubMed ID: 8913452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.